Light-Based Procedures in Pediatric Dermatology


Therapy

 Blue light

 Green light

 Turquoise light

Therapy protocol

 Protective eyewear

 Daily until safe bilirubin levels are established




Table 27.1
First line









Neonatal hyperbilirubinemia

B



Light-Emitting Diode (LED)


LED is considered a single-color light therapy. The distinctive feature of LED is that it is a broad-spectrum continuous wave of visible light. Blue light is within the spectral range of 407–425 nm (peak 420 nm) and red light 550–700 nm (660 nm). Blue or red light phototherapy can also be considered as second-line acne treatment in pregnant or lactating females [3].

















Therapy

 Blue-light (B) [4]

 Red-light

 Blue-red light (A) [5]

Therapy protocol

 Twice daily × 4 weeks



Table 27.2
Second line









Acne, mild to moderate inflammatory

B [4]


Intense Pulsed Light (IPL)


IPL uses broad spectrum, pulse-delivered polychromatic light. Considerations for the use of IPL in the pediatric population include pain, edema, erythema, crusting and blistering.















Therapy

 IPL

 IPL + PDT (photodynamic therapy) [6]

Therapy protocol

 Not established (typically three sessions with 3- to 4-week intervals in between)



Table 27.3
Third line









Acne, non-inflammatory and inflammatory

C


Photodynamic Therapy (PDT)


PDT utilizes a photosensitizing agent, commonly 5-aminolevulinic acid (ALA), to increase the effect of an ensuing light- (or laser-) based therapy [7]. Considerations for the use of PDT in the pediatric population include pain, burning, swelling, redness, transient hyperpigmentation, and superficial exfoliation. PDT can be considered as an alternative treatment of extensive viral warts in immunosuppressed individuals.





















Therapy ALAPDT

 ALA+ Red-light (B)

 ALA + Blue-light (C)

 ALA + IPL (C) [8]

Therapy protocol

 20 % ALA moisturizing cream

 0.5 % ALA liposomal spray

 Short (15–30 min) or longer (3 h) incubation time



Table 27.4
Third line


















Acne, moderate to severe inflammatory

B [6, 9]

Hidradenitis suppurativa

C [10]

Viral warts, recalcitrant

A [1114]

Facial flat warts

C [15, 16]



Phototherapy


Phototherapy is utilized to treat a variety of photodermatoses, including photoresponsive inflammatory and autoimmune conditions.


UVA Phototherapy


UVA utilizes ultraviolet light in the 320–400 nm wavelength (UVA1 340–400 nm). This long-wave ultraviolet light is often combined with the oral drug psoralen (PUVA). Considerations for the use of PUVA in the pediatric population include the ability of the child to comply with safety procedure and to hold still in a closed booth, ingesting a systemic psoralen and tolerating any associated nausea, and the cumulative risk for the potential development of skin cancer.























Therapy

 UVA

 UVA1 (B) [17]

 UVA + psoralen (PUVA)

Therapy protocol

 Requires strict 24 h of protective eyewear

 Once to twice weekly treatment sessions; at least 48–72 h apart

 Psoralens can be delivered topically, given as a bath, or orally

 Psoralen is taken 45–60 min prior to UVA exposure



Table 27.5
First line















Morphea (generalized)

[1821]

GVHD

D [22]

Granuloma annulare (generalized)

E



Table 27.6
Second line

































Psoriasis

A [23]

Morphea

B

Atopic dermatitis

B [24]

Pityriasis lichenoides

C [2527]

Alopecia areata

B [28, 29]

Solar urticaria

E [30, 31]

Mastocytosis

E [32, 33]

Vitiligo

B [3436]

CTCL/Mycosis fungoides

B [3739]


UVB Phototherapy


UVB is ultraviolet light that falls in the 280–320 nm wavelength spectrum of light. UVB has been found to be an effective, safe, well-tolerated, and practical alternative treatment modality in the pediatric population, and has surpassed PUVA as the phototherapy of choice in some immune mediated skin diseases.



















Therapy

 UVA/UVB

 Broadband UVB (bUVB)

 Excimer laser (308 nm)

 Narrowband UVB (311–312 nm)

Therapy protocol

 Two to three times weekly protocol



Table 27.7
Second line













































Atopic dermatitis

B [40, 41]

Psoriasis

A [23, 42]

Vitiligo

A [43]

Pityriasis lichenoides

B [44]

Morphea

E [45]

Alopecia areata

D [46]

Mycosis fungoides

B [47]

Pruritus (generalized)

B [48]

Nodular prurigo

D [49]

Hydroa vacciniforme

E [50, 51]

Granuloma annulare

E [52, 53]

Lichen planus

B [54]

Pityriasis rosea

B [55]


Photopatch Testing


Photopatch testing is used to further investigate patients with a history of photosensitivity. Ultraviolet radiation is employed while undergoing patch testing with various allergens. Before undergoing photopatch testing, it is prudent to rule out the possibility of the patient having another endogenous photosensitivity, such as polymorphous light eruption (PLE).













Therapy

 UVA

Therapy protocol

 Back is exposed to UV light following patch take down on day 2 (after 24–48 h)



Table 27.8
First line












Photoallergic contact dermatitis

[56]

Photoallergic drug eruption

[56]


Extracorporeal Photochemotherapy


Extracorporeal photopheresis (ECP) is used mainly to treat autoimmune diseases by removing abnormal cells from the bloodstream via lymphocyte activation and cell death. The blood is first separated and treated with a photosensitizing agent, and then irradiated with UV light. Following this photodynamic therapy, the blood is then returned to the patient.













Therapy

 8-MOP + UVA

Therapy protocol

 4 h per day on two consecutive days, each month



Table 27.9
First line









Mycosis fungoides (erythrodermic) Sezary’s syndrome

D



Table 27.10
Second line

















SLE

C [57]

Lichen planus (erosive)

D [58]

Chronic GVHD

E [59]

CTCL

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 13, 2017 | Posted by in Dermatology | Comments Off on Light-Based Procedures in Pediatric Dermatology

Full access? Get Clinical Tree

Get Clinical Tree app for offline access